{
    "Trade/Device Name(s)": [
        "QuickVue Influenza A+B Test",
        "QuickVue\u00ae Influenza A+B Test"
    ],
    "Submitter Information": "Quidel Corporation",
    "510(k) Number": "K180288",
    "Predicate Device Reference 510(k) Number(s)": [
        "K162438"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PSZ"
    ],
    "Summary Letter Date": "January 31, 2018",
    "Summary Letter Received Date": "February 2, 2018",
    "Submission Date": "January 25, 2018",
    "Regulation Number(s)": [
        "21 CFR 866.3328"
    ],
    "Regulation Name(s)": [
        "Influenza virus antigen detection test systems"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza A antigen",
        "Influenza B antigen"
    ],
    "Specimen Type(s)": [
        "Nasal swab",
        "Nasopharyngeal swab"
    ],
    "Specimen Container(s)": [
        "Extraction Reagent Tube"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunological assay"
    ],
    "Methodologies": [
        "Antigen extraction",
        "Test strip visual detection"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "Kit",
        "Strip test",
        "Tube"
    ],
    "Document Summary": "FDA 510(k) summary for QuickVue Influenza A+B Test for rapid visual detection of influenza A and B antigens from nasal and nasopharyngeal swabs",
    "Indications for Use Summary": "Aids in the rapid differential diagnosis of acute influenza type A and type B viral infections by detecting their antigens in nasal and nasopharyngeal swab specimens from symptomatic patients; not intended to detect influenza C antigens and for professional/laboratory use only.",
    "fda_folder": "Microbiology"
}